Crystalplex

About:

Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets.

Website: http://www.crystalplex.com

Top Investors: Pittsburgh Life Sciences Greenhouse

Description:

Crystalplex provides cutting-edge fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company products provide test results from smaller samples and with reduced time, lower labor costs, and less expensive instrumentation than currently possible. It also provides better results for drug discovery and diagnostic decision making. Crystaplex specializes in the cost-effective manufacturing of the most robust Quantum Dots available for illumination and solar energy applications. The proprietary technology in their SapphireTM QDs provides a stable crystal design, flexible polymer matrix morphology, and meets environmentally responsible yet demanding performance requirements for high-end consumer electronics applications such as LCD TVs, displays, and high-CRI architectural lighting. Crystaplex was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.

Total Funding Amount:

$3.22M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)crystalplex.com

Founders:

Tom Petzinger

Number of Employees:

1-10

Last Funding Date:

2018-06-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai